Evaluation of an Early Management Strategy for Obstructive Sleep Apnea

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary objective of this study is to evaluate the effect of more timely care for obstructive sleep apnea (OSA) on adherence to positive airway pressure (PAP) therapy at three months after treatment initiation. The secondary objectives are to determine if earlier care improves the treatment effect of PAP on patient reported sleepiness, quality of life and patient satisfaction. We will also evaluate the impact of shorter wait times on patient engagement in therapy by assessing initial acceptance of PAP therapy, patient activation and self-efficacy with respect to OSA treatment. The study hypothesis is that the early management strategy will be superior to usual care with respect to the primary outcome of PAP adherence at three months.
Epistemonikos ID: e1d711f1f6e0ea8681b7cf1e9849598c6888597f
First added on: May 07, 2024